GlobeImmune Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2011
2012
2013
2014
2015
Cash & Short Term Investments
71,318.50
2,002.90
5,924.20
16,812.50
9,900.70
Other Current Assets
422.00
886.40
900.90
999.90
1,190.10
Total Current Assets
71,740.50
2,889.30
6,825.10
17,812.40
11,090.80
Net Property, Plant & Equipment
2,068.50
1,251.80
492.80
455.80
209.70
Total Investments and Advances
100.00
100.00
100.00
100.00
-
Other Assets
-
-
-
-
205.60
Total Assets
73,909.00
4,241.20
7,417.90
18,368.10
11,506.10
Accounts Payable
1,314.90
2,957.20
1,736.60
572.60
234.10
Income Tax Payable
-
-
115.80
-
-
Other Current Liabilities
12,127.40
5,393.70
4,562.10
4,599.90
3,991.40
Total Current Liabilities
13,442.30
8,350.90
6,414.50
5,172.50
4,225.40
Long-Term Debt
-
-
198.00
-
-
Other Liabilities
24,061.70
17,217.90
12,444.90
7,592.10
4,292.30
Total Liabilities
37,504.00
25,568.80
19,057.40
12,764.60
8,517.70
Common Equity (Total)
36,405.00
196,124.90
199,321.80
5,603.50
2,988.40
Total Shareholders' Equity
36,405.00
21,327.70
11,639.40
5,603.50
2,988.40
Total Equity
36,405.00
21,327.70
11,639.40
5,603.50
2,988.40
Liabilities & Shareholders' Equity
73,909.00
4,241.20
7,417.90
18,368.10
11,506.10
Preferred Stock (Carrying Value)
-
174,797.20
187,682.40
-
-

About GlobeImmune

View Profile
Address
1450 Infinite Drive
Louisville Colorado 80027
United States
Employees -
Website http://www.globeimmune.com
Updated 07/08/2019
GlobeImmune, Inc. is a biopharmaceutical company. It engages in developing therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform. The company was founded by Donald Bellgrau, Richard C.